Pulmonary x‐ray computed tomographic (CT) and magnetic resonance imaging (MRI)
research and development has been motivated, in part, by the quest to subphenotype …

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity
and mortality worldwide. COPD is defined by irreversible airflow obstruction. It is a …

The Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) study,
which began in 2007, is an ongoing multicenter observational cohort study of more than …

Lung imaging is increasingly being used to diagnose, quantify, and phenotype chronic
obstructive pulmonary disease (COPD). Although spirometry is the gold standard for the …

A number of chronic diseases have benefited from both imaging and personalised medicine,
but unfortunately, for patients with chronic obstructive pulmonary disease (COPD), there has …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized
by both small airway and parenchymal abnormalities. There is increasing evidence to …

Multidetector-row computed tomography (MDCT) can be used to quantify morphological
features and investigate structure/function relationship in COPD. This approach allows a …

FEV1, measured using spirometry, provides a straightforward, widely available, and
inexpensive global measurement of airflow limitation and lung function. For decades, FEV1 …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease that is
characterized by chronic airflow limitation. Unraveling of this heterogeneity is challenging …

Chronic obstructive pulmonary disease (COPD) is expected to climb on the podium of the
leading causes of mortality worldwide in the upcoming decade. Clinical diagnosis of COPD …